Keynote Opening Address: A Historic Review to Celebrating 40 Years of Research Against RAS-Mutant Cancers

Time: 9:00 am
day: Day One


  • After forty years since the isolation identification of the first human onco cancer gene, we revisit and review a history of the directions taken to target RAS
  • From multitude thousands of fantastic efforts strategies taken to targeting RAS, we can consider assess a state-of-the-art in RAS therapeutics
  • At the milestone of the first-ever targeted RAS therapeutics, we deliberate future issues and opportunities for this industry